OurBrainBank at SNO 2023
Join OurBrainBank for Glioblastoma at SNO 2023
New York Times Op-ed by Board Member Sundas Hashmi
My Brother Died of Brain Cancer. 20 Years Later, I Had It, Too.
I was told it didn’t run in families. Was it just chance?
2020 New York Times Op-ed by Jessica Morris and Jana Bennett
We Are Living With Brain Cancer. Here’s How Biden Could Help Us.
Like Beau Biden, we have glioblastoma. It doesn’t get the attention it should.
Our GBM Story: Margaret and Glenn
Margaret writes about her and her husband Glenn’s glioblastoma experience, including becoming activists for better treatment.
Brain Surgery Tips from the National Brain Tumor Society
The National Brain Tumor Society has good tips on what to expect when having brain surgery, including ideas for care partners. People who receive a glioblastoma diagnosis are usually completely shocked and not prepared, this information may help.
Australian professor Richard Scolyer documents his glioblastoma journey
Prof. Richard Scolyer is an Australian pathologist who’s bravely sharing his GBM journey
Cancer Moonshot
The Cancer Moonshot is focused on increased investment, data collaboration, quality of life for people with cancer, including brain tumors like glioblastoma, and more.
OurBrainBank Wins Forbes EQ BrandVoice 2024: First Article Features Jessica Morris’s book
OBB founder Jessica Morris’s book is excerpted by Forbes.
Take our survey about disparities in GBM treatment
Have you or a loved one received a GBM diagnosis? We want to hear about your experience.
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
